Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Alkermes (ALKS) over the last 14 years, with Sep 2025 value amounting to $307,000.

  • Alkermes' Gains from Investment Securities rose 4.78% to $307,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 1.82%. This contributed to the annual value of $29.6 million for FY2024, which is 4.08% up from last year.
  • As of Q3 2025, Alkermes' Gains from Investment Securities stood at $307,000, which was down 81.70% from $1.7 million recorded in Q2 2025.
  • Alkermes' Gains from Investment Securities' 5-year high stood at $28.8 million during Q1 2025, with a 5-year trough of $293,000 in Q3 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $1.7 million (2025), whereas its average is $8.2 million.
  • Per our database at Business Quant, Alkermes' Gains from Investment Securities skyrocketed by 3,025.53% in 2021 and then plummeted by 89.75% in 2022.
  • Quarterly analysis of 5 years shows Alkermes' Gains from Investment Securities stood at $2.9 million in 2021, then crashed by 89.75% to $301,000 in 2022, then surged by 695.35% to $2.4 million in 2023, then slumped by 85.63% to $344,000 in 2024, then increased by 4.78% to $307,000 in 2025.
  • Its Gains from Investment Securities stands at $307,000 for Q3 2025, versus $1.7 million for Q2 2025 and $28.8 million for Q1 2025.